Our previous study also demonstrated that overexpression of DCX and its nucleocytoplasmic transport via the RanGTPase signaling pathway enhanced glioma invasiveness and proliferation (Ayanlaja et al. 2020). The gene discussed is DCX; the disease is glioma.